AAAAAA
Results: 76-100/137
Authors:
HUNTER AJ
GREEN AR
CROSS AJ
Citation: Aj. Hunter et al., ANIMAL-MODELS OF ACUTE ISCHEMIC STROKE - CAN THEY PREDICT CLINICALLY SUCCESSFUL NEUROPROTECTIVE DRUGS, Trends in pharmacological sciences, 16(4), 1995, pp. 123-128
Authors:
GREEN AR
CROSS AJ
GOODWIN GM
Citation: Ar. Green et al., REVIEW OF THE PHARMACOLOGY AND CLINICAL-PHARMACOLOGY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA OR ECSTASY), Psychopharmacology, 119(3), 1995, pp. 247-260
Authors:
SYDSERFF SG
CROSS AJ
GREEN AR
Citation: Sg. Sydserff et al., THE NEUROPROTECTIVE EFFECT OF CHLORMETHIAZOLE ON ISCHEMIC NEURONAL DAMAGE FOLLOWING PERMANENT MIDDLE CEREBRAL-ARTERY ISCHEMIA IN THE RAT, Neurodegeneration, 4(3), 1995, pp. 323-328
Authors:
KEIL U
BUSFIELD SJ
FARR TJ
PAPADIMITRIOU J
GREEN AR
BEGLEY CG
KLINKEN SP
Citation: U. Keil et al., EMERGENCE OF MYELOID CELLS FROM CULTURES OF J2E ERYTHROID-CELLS IS LINKED WITH KARYOTYPIC ABNORMALITIES, Cell growth & differentiation, 6(4), 1995, pp. 439-448
Authors:
MURRELL AM
BOCKAMP EO
GOTTGENS B
CHAN YS
CROSS MA
HEYWORTH CM
GREEN AR
Citation: Am. Murrell et al., DISCORDANT REGULATION OF SCL TAL-1 MESSENGER-RNA AND PROTEIN DURING ERYTHROID-DIFFERENTIATION/, Oncogene, 11(1), 1995, pp. 131-139
Authors:
MURRELL AM
GREEN AR
Citation: Am. Murrell et Ar. Green, REGULATION OF LINEAGE RESTRICTED HEMATOPOIETIC TRANSCRIPTION FACTORS IN CELL HYBRIDS, Oncogene, 10(4), 1995, pp. 631-639
Authors:
GOTTGENS B
BOCKAMP EO
MCLAUGHLIN F
GREEN AR
Citation: B. Gottgens et al., LINEAGE RESTRICTED ACTIVITY OF THE SCL TAL-1 PROMOTER/, Experimental hematology, 23(8), 1995, pp. 781-781
Authors:
GOTTGENS B
GREEN AR
Citation: B. Gottgens et Ar. Green, RETINOIC ACID AND THE DIFFERENTIATION OF LYMPHOHEMATOPOIETIC STEM-CELLS, BioEssays, 17(3), 1995, pp. 187-189
Authors:
NACHEVA E
GRACE C
HOLLOWAY TL
GREEN AR
Citation: E. Nacheva et al., COMPARATIVE GENOMIC HYBRIDIZATION IN ACUTE MYELOID-LEUKEMIA - A COMPARISON WITH G-BANDING AND CHROMOSOME PAINTING, Cancer genetics and cytogenetics, 82(1), 1995, pp. 9-16
Authors:
NACHEVA E
HOLLOWAY T
CARTER N
GRACE C
WHITE N
GREEN AR
Citation: E. Nacheva et al., CHARACTERIZATION OF 20Q DELETIONS IN PATIENTS WITH MYELOPROLIFERATIVEDISORDERS OR MYELODYSPLASTIC SYNDROMES, Cancer genetics and cytogenetics, 80(2), 1995, pp. 87-94
Authors:
MCHARDY IM
GREEN AR
DONE C
PUCHNAREWICZ EM
MASON KO
BRANDUARDIRAYMONT G
JONES MH
Citation: Im. Mchardy et al., LOW-ENERGY X-RAY SPECTRAL VARIABILITY OF NGC-4051, Monthly Notices of the Royal Astronomical Society, 273(3), 1995, pp. 549-558
Authors:
SPEIRS V
BIRCH MA
BONEWALSH E
GREEN AR
GALLAGHER JA
WHITE MC
Citation: V. Speirs et al., INTERLEUKIN-3 - A PUTATIVE PROTECTIVE FACTOR AGAINST BREAST-CANCER WHICH IS SECRETED BY MALE BUT NOT FEMALE BREAST FIBROBLASTS, International journal of cancer, 61(3), 1995, pp. 416-419
Authors:
COLADO MI
GREEN AR
Citation: Mi. Colado et Ar. Green, THE SPIN TRAP REAGENT ALPHA-PHENYL-N-TERT-BUTYL NITRONE PREVENTS ECSTASY-INDUCED NEURODEGENERATION OF 5-HYDROXYTRYPTAMINE NEURONS, European journal of pharmacology, 280(3), 1995, pp. 343-346
Authors:
PRESTA A
GREEN AR
ZELAZOWSKI A
STILLMAN MJ
Citation: A. Presta et al., COPPER-BINDING TO RABBIT LIVER METALLOTHIONEIN - FORMATION OF A CONTINUUM OF COPPER(I)-THIOLATE STOICHIOMETRIC SPECIES, European journal of biochemistry, 227(1-2), 1995, pp. 226-240
Authors:
COLADO MI
WILLIAMS JL
GREEN AR
Citation: Mi. Colado et al., THE HYPERTHERMIC AND NEUROTOXIC EFFECTS OF ECSTASY (MDMA) AND 3,4-METHYLENEDIOXYAMPHETAMINE (MDA) IN THE DARK-AGOUTI (DA) RAT, A MODEL OF THE CYP2D6 POOR METABOLIZER PHENOTYPE, British Journal of Pharmacology, 115(7), 1995, pp. 1281-1289
Authors:
CROSS AJ
JONES JA
SNARES M
JOSTELL KG
BREDBERG U
GREEN AR
Citation: Aj. Cross et al., THE PROTECTIVE ACTION OF CHLORMETHIAZOLE AGAINST ISCHEMIA-INDUCED NEURODEGENERATION IN GERBILS WHEN INFUSED AT DOSES HAVING LITTLE SEDATIVEOR ANTICONVULSANT ACTIVITY, British Journal of Pharmacology, 114(8), 1995, pp. 1625-1630
Authors:
SYDSERFF SG
CROSS AJ
WEST KJ
GREEN AR
Citation: Sg. Sydserff et al., THE EFFECT OF CHLORMETHIAZOLE ON NEURONAL DAMAGE IN A MODEL OF TRANSIENT FOCAL ISCHEMIA, British Journal of Pharmacology, 114(8), 1995, pp. 1631-1635
Authors:
BOCKAMP EO
MCLAUGHLIN F
MURRELL AM
GOTTGENS B
ROBB L
BEGLEY CG
GREEN AR
Citation: Eo. Bockamp et al., LINEAGE-RESTRICTED REGULATION OF THE MURINE SCL TAL-1 PROMOTER/, Blood, 86(4), 1995, pp. 1502-1514
Authors:
ASIMAKOPOULOS FA
HOLLOWAY TL
NACHEVA E
SCOTT MA
FENAUX P
GREEN AR
Citation: Fa. Asimakopoulos et al., DETECTION OF CHROMOSOME 20Q DELETIONS IN BONE-MARROW METAPHASES BUT NOT PERIPHERAL-BLOOD GRANULOCYTES IN PATIENTS WITH MYELOPROLIFERATIVE DISORDERS OR MYELODYSPLASTIC SYNDROMES, Blood, 86(10), 1995, pp. 1319-1319
Authors:
ASIMAKOPOULOS FA
GILBERT JGR
ALDRED MA
MESSINEZY M
PEARSON TC
GREEN AR
Citation: Fa. Asimakopoulos et al., INTERSTITIAL DELETION CONSTITUTES THE MAJOR MECHANISM FOR LOSS OF HETEROZYGOSITY ON CHROMOSOME 20Q IN MYELOPROLIFERATIVE DISORDERS, Blood, 86(10), 1995, pp. 1320-1320
Authors:
OCONNOR SJM
NACHEVA E
GREEN AR
Citation: Sjm. Oconnor et al., COMBINED IMMUNOPHENOTYPING AND FLUORESCENT IN-SITU HYBRIDIZATION IS ASENSITIVE TECHNIQUE FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE, Blood, 86(10), 1995, pp. 2936-2936
Authors:
SINCLAIR P
BROADBENDT V
HARPER P
GREEN AR
NACHEVA E
Citation: P. Sinclair et al., CHROMOSOME 3Q IN ANNL - BREAK POINTS CLARIFIED BY CHROMOSOME PAINTING, American journal of human genetics, 57(4), 1995, pp. 416-416
Authors:
ALDRED MA
HUMPHRAY SJ
GWILLIAM R
BENTLEY DR
GREEN AR
Citation: Ma. Aldred et al., A YAC CONTIG SPANNING THE REGION OF CHROMOSOME 20Q THAT IS DELETED INMYELOPROLIFERATIVE DISORDERS, American journal of human genetics, 57(4), 1995, pp. 1480-1480
Authors:
TANIGAWA T
ROBB L
GREEN AR
BEGLEY CG
Citation: T. Tanigawa et al., CONSTITUTIVE EXPRESSION OF THE PUTATIVE TRANSCRIPTION FACTOR SCL ASSOCIATED WITH PROVIRAL INSERTION IN THE MYELOID LEUKEMIC-CELL LINE WEHI-3BD(-1), Cell growth & differentiation, 5(6), 1994, pp. 557-561
Authors:
MAHENDRA P
AGER S
BEDLOW AJ
BLOXHAM DM
GREEN AR
MARCUS RE
Citation: P. Mahendra et al., 2 UNUSUAL NEUROLOGICAL PRESENTATIONS OF GRANULOCYTIC SARCOMA IN PHILADELPHIA-POSITIVE CHRONIC MYELOID-LEUKEMIA, Leukemia & lymphoma, 15(3-4), 1994, pp. 351-355